logo
logo
  • Online Library
    • Projects
    • Companies
  • Congress
    • Programme
    • Speakers
    • Committees
    • Tickets
    • General information
    • Sponsors
    • Poster Presentation Guidelines
  • Members
    • Catch a Rising Star
    • Student Exchange
    • Community Request
  • News
    • XR4REHAB Community Request
    • Newsletter Advertisement
    • Events Calendar
  • Webinars
    • Co-production of a Virtual Reality Game for MS patients
    • Seize the Moment: XR Transforming Neuro Rehab!
    • The use of VR in acute orthopaedic trauma: challenges and opportunities
    • Implementation of Neuro Rehabilitation OnLine
    • Medical Device Regulation Webinar
    • VR4LongCovid Session
    • VR4LongCovid: The breathtaking results
  • Podcasts
  • Forum
  • About us
    • Website
    • Partners
    • Blueprint
    • Contact
  1. Home
  2. VR4REHAB-018

Virtual Reality for the Management of Chronic Pain – The VIPA Study

Jordan Tsigarides(1), Vanessa Grove(1), Jacqueline Chipping(1), Susan Miles(1), Nicholas Shenker(2), Saber Sami(1), Alexander Macgregor(1)

(1)Norwich Medical School, University of East Anglia, Norwich, United Kingdom
(2)Addenbrookes University Hospital, Cambridge, United Kingdom

 

Introduction
Chronic pain is debilitating, prevalent and one of the most prominent causes of disability worldwide. Current non-pharmacological treatments for pain conditions such as Fibromyalgia Syndrome (FMS) are labour intensive to implement and not widely available, especially during the pandemic.

Virtual reality (VR) has shown promise in the management of pain in acute settings1 with improvements in pain reporting corresponding to reduced activity within the pain neuromatrix in fMRI studies2. However, studies of use in chronic pain are limited, including diverse groups of patients with widely different interventions.

The VIPA Study is investigating the impact of different VR characteristics on acceptability and pain through a set of feasibility studies in specific chronic pain cohorts. Here we report on the VR experience and influence on pain among patients with FMS.

Methods
Patients with FMS were recruited through outpatient clinics at the Norfolk and Norwich University Hospital. Four VR systems representing the spectrum of commercially available technologies were used by participants in a random order, for approximately five minutes each. The interactive VR experience used with each head-mounted display (HMD) was co-developed alongside industry partners (Orbital Global). Participants were immersed within a naturalistic environment, situated on a wooden boat travelling slowly along a calm river surrounded by trees and hills. The interactive element involved the user shooting targets that appear using handheld controllers.

Baseline questionnaires included the McGill pain questionnaire short form (MPQ-SF; total score: 0-45) and a pain visual analogue scale (VAS; 0-10). VAS data were also reported after use of each HMD. Subjective experience questionnaires collected data with 7-point Likert scale rating questions (1=strongly disagree to 7=strongly agree). The VR sickness questionnaire gained side-effect data (VRSQ; total severity score: 0-100). Likert-scale data were dichotomised (rating ≤3: disagree, rating ≥5: agree).

Results and Discussion
13 participants with FMS were included (mean age 41.8±15.6, 92.3% female) with moderate self-reported pain at baseline (mean MPQ 25.5±8.8, VAS 6.0±1.7). Only 30.8% had previous VR exposure. Across HMDs, side effects were mild and infrequent (average mean VRSQ 17.3±9.7). Participants reported reduced pain VAS scores following use of each headset compared to baseline (see table 1). Following use of the Oculus Rift S, 100% agreed that they felt immersed within the virtual world (mean rating 6.46±0.78) and 92% agreed that they had more attention for the experience than for their own thoughts (mean rating 6.54±0.88). 77% also agreed that they lost track of time whilst undergoing the VR experience (mean rating 5.85±1.46).

Table 1: VAS data following use of each VR HMD

Our results strengthen the rationale for use of therapeutic VR in chronic pain. FMS patients found VR immersive and engaging, favouring the Oculus Rift S. Patients reported significantly lower pain regardless of the HMD used, with minimal side effects. This feasibility work paves the way for a larger clinical trial investigating efficacy, dose-response and impact on medication use.

Conclusions
Therapeutic VR provides an accessible, non-pharmacological pain management option of the future with clear benefits over traditional approaches given its ability to be delivered in patients’ homes.

 

References

1. Dascal J, Reid M, Ishak WW, Spiegel B, Recacho J, Rosen B, Danovitch I. Virtual reality and medical inpatients: A systematic review of randomized, controlled trials. Innov Clin Neurosci 2017;14(1-2):14-21

2. Hoffman HG, Richards TL, Coda B, Bills AR, Blough D, Richards AL, Sharar SR. Modulation of thermal pain-related brain activity with virtual reality: evidence from fMRI. NeuroReport 2004;15(8):1245-8

3. Jones T, Moore T and Choo J. The impact of virtual reality on chronic pain. PLoS One 2016;11(12):e0167523

Navigation

Publications

News

Congress

Partners

About

Contact

Event 2025

Program

Guest speakers

Tickets

More information

Partners

EuroXR

Games Solutions Lab

Sint Maartenskliniek

Teesside University

All partners

Tickets available

Tickets for the XR4REHAB Conference 2025 are available now!

Get tickets

© 2025 XR4REHAB

Privacy Policy

Event 2025

Program

Guest speakers

Tickets

More information

Tickets available

Tickets for our 2023 XR4REHAB congress are available now!

Tickets

© 2023 XR4REHAB

Privacy Policy

We use cookies

XR4REHAB uses cookies and similar technologies to provide you with a better experience and to measure your interactions with our websites, products and services. If you're okay with that, click "Accept". To restrict data sharing, click on "Cookie settings". You can always change your settings. See our privacy policy for our privacy statement and cookie policy.
Cookie settings
Accept

Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT
Stay connected

Want to make sure you have the latest information about VR4REHAB? Subscribe to our newsletter.

Enter your email address